Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03123939 |
Title | Phase III B in Acute Lymphoblastic Leukemia |
Recruitment | Completed |
Gender | |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | ITA | FRA | ESP | DEU | CAN | BEL | AUT |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Wien | A 1090 | Austria | Details | ||
Novartis Investigative Site | Gent | 9000 | Belgium | Details | ||
Novartis Investigative Site | Toronto | Ontario | M5G 1X8 | Canada | Details | |
Novartis Investigative Site | Montreal | Quebec | H3T 1C5 | Canada | Details | |
Novartis Investigative Site | Paris Cedex 10 | 75475 | France | Details | ||
Novartis Investigative Site | Paris Cedex | 75019 | France | Details | ||
Novartis Investigative Site | Frankfurt | 60590 | Germany | Details | ||
Novartis Investigative Site | Monza | MB | 20900 | Italy | Details | |
Novartis Investigative Site | Kyoto | 606 8507 | Japan | Details | ||
Novartis Investigative Site | Oslo | 0424 | Norway | Details | ||
Novartis Investigative Site | Esplugues de Llobregat | Barcelona | 08950 | Spain | Details |